New Montefiore Study Demonstrates How Doctors & Caregivers Can Partner To Improve Children s Care At Home After Hospitalization
USA - English
News provided by
Share this article
Share this article
NEW YORK, Jan. 6, 2021 /PRNewswire/ Many children need to take medication at home after being discharged from the hospital. Recent research conducted at the Children s Hospital at Montefiore (CHAM) and Albert Einstein College of Medicine found that 70 percent of caregivers either mismanage or don t fully understand hospital discharge medication instructions, leading to problems such as wrong dosage or confusion about side effects. Now, the same CHAM investigators looked at ways to correct this issue and published their results in
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Study of patients undergoing abdominal aortic aneurysm repair suggests screening guidelines may .
Society for Vascular SurgeryJanuary 5, 2021 GMT
Rosemont, Ill., Jan. 05, 2021 (GLOBE NEWSWIRE) A retrospective study analyzing approximately 55,000 patients undergoing abdominal aortic aneurysm (AAA) repair suggests current AAA screening guidelines may be inadequate in detecting a significant number of new cases. Additionally, expanding screening for certain population segments may be warranted. The study patients were enrolled in the Vascular Quality Initiative between years 2003 and 2019.
The study was spearheaded by Jeffrey E. Indes, MD, vascular surgeon at Montefiore Einstein Center for Heart and Vascular Care, and results were published in the December 2020 edition of the Journal of Vascular Surgery.
Neurology.
“This study is the first to show that the presence of neurological symptoms, particularly stroke and confused or altered thinking, may indicate a more serious course of illness, even when pulmonary problems aren’t severe,” the study’s co-author Dr. David Altschul, chief of neurovascular surgery at Montefiore Health System and Albert Einstein College of Medicine in New York City, said in a news release.
“Hospitals can use this knowledge to prioritize treatment and, hopefully, save more lives during this pandemic.”
In concluding their findings, Altschul and his team were able to analyze data on more than 4,700 coronavirus-positive patients who were admitted to the Montefiore system between March 1 and April 16.
COVID Survival Declines When Brain Affected: Study
By Robert Preidt
HealthDay Reporter
MONDAY, Dec. 28, 2020 (HealthDay News) Hospitalized COVID-19 patients with brain complications such as stroke and confusion have an increased risk of death, a new study shows.
The findings could improve care and save lives during the pandemic, the researchers said. This study is the first to show that the presence of neurological symptoms, particularly stroke and confused or altered thinking, may indicate a more serious course of illness, even when pulmonary problems aren t severe, said study co-author Dr. David Altschul, chief of neurovascular surgery at Montefiore Health System and Albert Einstein College of Medicine in New York City.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Soterix Medical Announces Expanded Clinical Trials for Alzheimer’s disease and Mild Cognitive Impairment
December 24, 2020 GMT
(PRNewsfoto/Soterix Medical)
NEW YORK, Dec. 24, 2020 /PRNewswire/ Soterix Medical Inc. , the global leader in non-invasive stimulation and synergistic brain imaging technologies, is pleased to report expanded clinical trials of its proprietary neuromodulation technologies for Alzheimer’s disease and Mild Cognitive Impairment. Adults over age 65 represent the fastest growing population in the US. Decline in cognitive abilities is a hallmark of advanced age and is associated with loss of independence and dementia risk. Over 50 million adults worldwide are diagnosed with Alzheimer’s disease or other dementia, which puts an enormous burden on individuals, their families and caretakers, and the healthcare system. Soterix Medical technologies are at the forefront